Physician profile
Christopher Warne
NPI 1093374340
$14,977.14
in general payments reported to CMS, 2019-2025
7 companies · $7,757 in 2025
The $7,757 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $345 · 2021: $125 · 2022: $319 · 2023: $673 · 2024: $5,759 · 2025: $7,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Travel and Lodging: $2,110 · Food and Beverage: $1,849 · Education: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Travel and Lodging | $2,109.94 |
| Food and Beverage | $1,848.71 |
| Education | $229.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,093.42 | 2024-2025 | Legion |
| Stryker Corporation | $2,458.59 | 2022-2025 | Mako, Gamma, Insignia |
| Medical Device Business Services, INC. | $1,858.10 | 2020-2025 | Na, Attune |
| Depuy Synthes Sales INC. | $337.93 | 2024-2025 | Tfn-Advance |
| Zimmer Biomet Holdings, INC. | $113.86 | 2023 | |
| Medtronic, INC. | $74.02 | 2023 | Unid_pass |
| Linkbio Corp | $41.22 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Warne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.